GWN Securities Inc. Has $4.73 Million Stock Holdings in Cardinal Health, Inc. $CAH

GWN Securities Inc. trimmed its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 7.9% during the third quarter, HoldingsChannel reports. The firm owned 29,870 shares of the company’s stock after selling 2,556 shares during the quarter. Cardinal Health comprises 1.1% of GWN Securities Inc.’s portfolio, making the stock its 15th largest holding. GWN Securities Inc.’s holdings in Cardinal Health were worth $4,729,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Exencial Wealth Advisors LLC lifted its holdings in Cardinal Health by 2.5% during the third quarter. Exencial Wealth Advisors LLC now owns 5,758 shares of the company’s stock worth $904,000 after acquiring an additional 140 shares in the last quarter. Liberty One Investment Management LLC raised its position in shares of Cardinal Health by 101.3% during the third quarter. Liberty One Investment Management LLC now owns 432,951 shares of the company’s stock worth $67,950,000 after purchasing an additional 217,826 shares during the period. CPC Advisors LLC acquired a new stake in shares of Cardinal Health during the third quarter worth about $2,287,000. GRIMES & Co WEALTH MANAGEMENT LLC bought a new position in shares of Cardinal Health during the 3rd quarter valued at about $815,000. Finally, Quent Capital LLC acquired a new position in shares of Cardinal Health in the 3rd quarter valued at approximately $35,000. Institutional investors own 87.17% of the company’s stock.

More Cardinal Health News

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal raised FY‑2026 EPS guidance to at least $10, cited accelerating specialty revenue (>$50B target) and announced strategic wins (IRA transition, new ContinuCare™ Pathway and a Publix partnership) — the core catalyst cited by management at J.P. Morgan. PR Newswire: Cardinal Health Raises Fiscal 2026 Outlook
• Positive Sentiment: Major business-media pieces note the guidance raise and specialty growth narrative as the reason for the stock jump and upgraded investor sentiment. Benzinga: Cardinal Health Lifts 2026 Profit Outlook
• Positive Sentiment: Barron’s explained why the guidance lift and specialty revenue trajectory make 2026 a constructive year for the stock, reinforcing buy‑side interest. Barron’s: Cardinal Health Stock Jumps on Guidance Raise
• Neutral Sentiment: The company’s full J.P. Morgan presentation/transcript provides detail on strategy execution and was used to support the guidance update; useful for modeling but not new on the headline guidance. Seeking Alpha: J.P. Morgan Presentation Transcript
• Neutral Sentiment: Analyst coverage and fair‑value views are shifting upward as sell‑side models incorporate the stronger FY26 guide and specialty momentum. Yahoo Finance: Analyst Upgrades & Specialty Focus
• Negative Sentiment: Short interest rose materially in December (≈23.6% increase to ~6.06M shares), which can add downside risk or volatility if sentiment reverses. (No article link provided)
• Negative Sentiment: Some commentary questions valuation after a multi‑year run and steep share gains — investors should weigh the beat/guidance versus premium multiples. Yahoo Finance: Has Cardinal Health Run Too Far?

Wall Street Analyst Weigh In

Several analysts have commented on CAH shares. Leerink Partners set a $240.00 target price on shares of Cardinal Health in a report on Tuesday. Citigroup upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $190.00 to $244.00 in a report on Friday. UBS Group boosted their price objective on shares of Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a research report on Friday, October 31st. TD Cowen increased their target price on Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, November 3rd. Finally, Weiss Ratings restated a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, October 8th. Fourteen equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $214.07.

Cardinal Health Trading Up 2.7%

Shares of CAH stock opened at $208.08 on Wednesday. The firm’s fifty day moving average price is $204.54 and its two-hundred day moving average price is $173.77. Cardinal Health, Inc. has a 1 year low of $119.92 and a 1 year high of $214.93. The firm has a market capitalization of $49.44 billion, a P/E ratio of 31.38, a PEG ratio of 1.47 and a beta of 0.65.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The business had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. During the same quarter in the previous year, the business earned $1.88 earnings per share. Cardinal Health’s quarterly revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, equities research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s dividend payout ratio is presently 30.77%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.